Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ingenious Ingredients (INGI) is a biotechnology company focused on the discovery and production of high-value functional ingredients for the food, beverage, and supplement industries. The company utilizes a proprietary technology platform that combines advanced fermentation techniques with metabolic engineering to create nature-identical compounds. Their primary focus areas include human milk oligosaccharides (HMOs) for infant nutrition and novel bioactive molecules for metabolic health and weight management. INGI aims to bridge the gap between pharmaceutical-grade efficacy and food-grade accessibility. The company was founded as a spin-off from BRAIN Biotech AG and is headquartered in Bensheim, Germany.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ingenious Ingredients.